Report cover image

Allergy Treatment Market, By Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies), By Treatment (Anti-allergy Drugs and Immunotherapy), and By Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and Sou

Publisher Coherent Market Insights
Published Aug 09, 2022
Length 170 Pages
SKU # CMI17372229

Description

Allergy Treatment Market, By Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies), By Treatment (Anti-allergy Drugs and Immunotherapy), and By Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Allergies are body's reaction to a normally harmless substance such as pollen, molds, animal dander, latex, certain foods, and insect stings. Allergy occurs when person reacts to substances in the environment that are harmless to most people. The treatment for an allergy depends on what people are allergic to. Medications, such as antihistamines and decongestants, used as a short-term treatment for allergies. Red and itchy skin can sometimes be treated with over-the-counter creams and lotions. Allergy immunotherapy could be the option for people with severe and persistent allergies who are unable to control their symptoms using the measures above.

Market Dynamics:

Increasing incidence of allergic disease or allergies, increasing demand for allergy treatment, continuous development of novel therapies to treat allergies, and increasing awareness among people are some major factors expected to boost growth of the global allergy treatment market. Globally, the prevalence of allergic diseases is rising rapidly in both developing and developed countries. Moreover, complexity and severity continue to increase especially in both children and young adults. According to the World Health Organization (WHO), around 30-40% of the world’s population is currently affected by one or more allergic conditions.

Therefore, there is an increasing demand for safe and effective treatment. In January 2021, the European Commission (EC) approved Palforzia for the treatment of peanut allergy, making it the first treatment for the condition. Produced by Aimmune Therapeutics, Palforzia is indicated in patients aged four to 17 years with a confirmed diagnosis of peanut allergy.

Key features of the study:
  • This report provides in-depth analysis of the global allergy treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global allergy treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Stallergenes Greer PLC, Sanofi SA, Novartis International AG, Dermapharm Holding SE, Leti Pharma, Johnson & Johnson, GlaxoSmithKline PLC, Nicox SA, F. Hoffmann-La Roche Ltd., Allergy Therapeutics, AbbVie (Allergan), Bausch Health Companies Inc., Teva Pharmaceutical Industries, ALK-Abello AS, and Alembic Pharmaceuticals Limited, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global allergy treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy treatment market.
Detailed Segmentation:
  • Global Allergy Treatment Market, By Type:
  • Eye Allergy
  • Rhinitis
  • Asthma
  • Skin Allergy
  • Food Allergies
  • Other Allergies
  • Global Allergy Treatment Market, By Treatment:
  • Anti-allergy Drugs
  • Immunotherapy
  • Global Allergy Treatment Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America

Table of Contents

170 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By Treatment
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increase in demand for allergy treatment
High cost of allergy treatment
High incidence of allergic diseases worldwide
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Allergy Treatment Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Allergy Treatment Market, By Type, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
Eye Allergy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Rhinitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Asthma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Skin Allergy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Food Allergies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Other Allergies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
6. Allergy Treatment Market, By Treatment, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
Anti-allergy Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
7. Allergy Treatment Market, By Geography, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Middle East and Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Rest of World
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
8. Competitive Landscape
Stallergenes Greer PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi SA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis International AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Dermapharm Holding SE
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Leti Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Nicox SA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Allergy Therapeutics PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AbbVie Inc. (Allergan)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bausch Health Companies Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
ALK-Abello AS
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Alembic Pharmaceuticals Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
9. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Allergy Treatment Market” - forecast to 2028

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us